New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...
New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
New Delhi, March 17 Zydus Lifesciences announced on Tuesday that it has entered into a licensing and supply agreement with Lupin to expand access to the diabetes treatment drug Semaglutide Injection (15 mg/3 ml) with a patient-friendly, reusable pen device in India.The agreement aims to...